QT
AMED

Quantbot Technologies’s Amedisys AMED Stock Holding History

Quantbot Technologies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,823
Closed -$910K – 1609
2025
Q1 		$910K Buy
+9,823
New +$906K 0.03% 714
2024
Q2 		– Sell
-8,260
Closed -$761K – 1402
2024
Q1 		$761K Buy
+8,260
New +$774K 0.04% 607
2023
Q3 		– Sell
-162
Closed -$14.8K – 1509
2023
Q2 		$14.8K Sell
162
-18,686
-99% -$1.53M ﹤0.01% 1434
2023
Q1 		$1.39M Buy
18,848
+9,280
+97% +$803K 0.1% 305
2022
Q4 		$799K Buy
+9,568
New +$863K 0.06% 437
2021
Q4 		– Sell
-21,319
Closed -$3.18M – 1467
2021
Q3 		$3.18M Buy
21,319
+13,833
+185% +$2.88M 0.23% 112
2021
Q2 		$1.83M Buy
7,486
+6,368
+570% +$1.67M 0.14% 209
2021
Q1 		$296K Sell
1,118
-1,313
-54% -$370K 0.03% 624
2020
Q4 		$713K Buy
2,431
+1,055
+77% +$271K 0.07% 337
2020
Q3 		$325K Buy
1,376
+456
+50% +$104K 0.04% 461
2020
Q2 		$182K Buy
920
+786
+587% +$147K 0.02% 451
2020
Q1 		$24K Buy
+134
New +$23.8K 0.02% 559
2019
Q4 		– Sell
-1,284
Closed -$168K – 1193
2019
Q3 		$168K Sell
1,284
-687
-35% -$89.4K 0.02% 724
2019
Q2 		$239K Sell
1,971
-897
-31% -$106K 0.02% 546
2019
Q1 		$353K Buy
+2,868
New +$360K 0.03% 526
2018
Q3 		– Sell
-2,856
Closed -$244K – 1235
2018
Q2 		$244K Buy
+2,856
New +$210K 0.02% 711
2018
Q1 		– Sell
-19,584
Closed -$1.03M – 1195
2017
Q4 		$1.03M Buy
+19,584
New +$1.03M 0.1% 301
2016
Q4 		– Sell
-2,699
Closed -$128K – 1043
2016
Q3 		$128K Buy
2,699
+2,369
+718% +$118K 0.01% 667
2016
Q2 		$16K Buy
+330
New +$16.7K ﹤0.01% 937

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Quantbot Technologies's AMED Position: Q2 2025 in Review

Quantbot Technologies sold out of Amedisys (AMED) in Q2 2025, closing a stake of 9,823 shares — an estimated $910K sold.

Quantbot Technologies first reported a position in AMED in Q2 2016 and held it in 19 quarters. The position peaked at $3.18M in Q3 2021. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Quantbot Technologies reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Quantbot Technologies sold 9,823 Amedisys shares in Q2 2025, an estimated $910K.
  • Quantbot Technologies first reported a position in Amedisys in Q2 2016 and held it in 19 quarters.
  • Quantbot Technologies's Amedisys position peaked at $3.18M in Q3 2021.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Quantbot Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.